|
Volumn 21, Issue 4, 2003, Pages 347-348
|
Industry ponders reimbursement crisis
a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ARTICLE;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
ECONOMICS;
EDUCATION;
HEALTH CARE COST;
REIMBURSEMENT;
UNITED STATES;
BIOTECHNOLOGY;
COMMERCE;
EDUCATION;
HEALTH CARE COSTS;
HEALTH CARE SECTOR;
PHARMACEUTICAL PREPARATIONS;
REIMBURSEMENT MECHANISMS;
UNITED STATES;
|
EID: 0037492236
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0403-347 Document Type: Note |
Times cited : (3)
|
References (0)
|